Harvard Health Blog

Anti-inflammatory medications and the risk for cardiovascular disease: A new study, a new perspective

By: Robert H. Shmerling, MD, Faculty Editor, Harvard Health Publications News last week about celecoxib shows how challenging it can be to understand the risks and benefits of newly developed drugs. This is particularly true when the findings of one study contradict those of past studies. And thatís exactly what has happened with celecoxib. Anti-inflammatory medications: pros and cons …

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In